Warning: The NCBI web site requires JavaScript to function. more...
Effectiveness of harm reduction programmes for injecting drug users in Dhaka city.
Azim T, Hussein N, Kelly R.
Harm Reduct J. 2005 Oct 25;2:22.
Related citations
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M; Amsterdam Cohort.
Addiction. 2007 Sep;102(9):1454-62.
Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
Foss AM, Watts CH, Vickerman P, Azim T, Guinness L, Ahmed M, Rodericks A, Jana S.
Addiction. 2007 Jan;102(1):114-25.
Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes.
Azim T, Bogaerts J, Yirrell DL, Banerjea AC, Sarker MS, Ahmed G, Amin MM, Rahman AS, Hussain AM.
AIDS. 2002 Jan 4;16(1):121-3.
Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle/syringe exchange program in Dhaka, Bangladesh.
Azim T, Chowdhury EI, Reza M, Faruque MO, Ahmed G, Khan R, Rahman M, Pervez MM, Jana S, Strathdee SA.
Subst Use Misuse. 2008 Dec;43(14):2124-44.
Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
Islam MM, Conigrave KM.
Drug Alcohol Rev. 2007 Jul;26(4):445-54. Review.
High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan.
Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem-ur-Rehman, Wray N.
Harm Reduct J. 2007 Feb 10;4:7.
Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F, Fatima M.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64. Epub 2008 Feb 20.
Bangladesh moves from being a low-prevalence nation for HIV to one with a concentrated epidemic in injecting drug users.
Azim T, Rahman M, Alam MS, Chowdhury IA, Khan R, Reza M, Rahman M, Chowdhury EI, Hanifuddin M, Rahman AS.
Int J STD AIDS. 2008 May;19(5):327-31.
Lessons learned from a peri-urban needle exchange.
Knittel AK, Wren PA, Gore L.
Harm Reduct J. 2010 Apr 29;7:8.
HIV transmission in Bangladesh: an analysis of IDU programme coverage.
Reddy A, Hoque MM, Kelly R.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S37-46. Epub 2008 Jan 18.
Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
Ngo AD, Schmich L, Higgs P, Fischer A.
Int J Drug Policy. 2009 Mar;20(2):179-82. Epub 2008 Feb 1.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.
Rhodes T, Platt L, Sarang A, Vlasov A, Mikhailova L, Monaghan G.
J Urban Health. 2006 Sep;83(5):911-25.
Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
Bruneau J, Daniel M, Kestens Y, Zang G, Généreux M.
J Epidemiol Community Health. 2008 Sep;62(9):804-10.
Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y, Qin G, Yin L, Chen K, Qian HZ, Hao C, Liang S, Zhu J, Xing H, Hong K, Shao Y.
AIDS. 2007 Dec;21 Suppl 8:S39-46.
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, Beatrice S, Smith L, Wethers J, Milliken J, Mildvan D, Yancovitz S, Friedman SR.
AIDS. 2005 Oct;19 Suppl 3:S20-5.
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
Mahanta J, Medhi GK, Paranjape RS, Roy N, Kohli A, Akoijam BS, Dzuvichu B, Das HK, Goswami P, Thongamba G; IBBA study team.
AIDS. 2008 Dec;22 Suppl 5:S59-68.
Effectiveness of needle/syringe exchange program in Tbilisi.
Otiashvili D, Gambashidze N, Kapanadze E, Lomidze G, Usharidze D.
Georgian Med News. 2006 Nov;(140):62-5.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on